# NAPOLI-2 (NCT04005339)

> NAPOLI-2: Fluorouracil, Leucovorin, and Nanoliposomal Irinotecan in Biliary Cancer

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT04005339
- Phase: PHASE2
- Status: ACTIVE_NOT_RECRUITING
- Sponsor: Georgetown University
- Conditions: Advanced Biliary Tract Cancer
- Interventions: Nanoliposomal Irinotecan; Leucovorin; Fluorouracil
- Enrollment: 48
- Primary outcome: The Efficacy of Fluorouracil, Leucovorin, and Nanoliposomal Irinotecan in Advanced Biliary Tract Cancers Following Progression on or Intolerance of Gemcitabine and Platinum Chemotherapy.

## Indexed commentary on NAPOLI-2 so far

Podcasts, YouTube videos and X posts we have indexed that name the trial. This is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.

- X threads: 3

## Order

Focused, $750 at most (a smaller delivered size costs its own price): https://www.erudio.com/contact?report=napoli-2-nct04005339